Drug companies' liability for the opioid epidemic

New England Journal of Medicine

Volumn 377, Issue 24, 2017, Pages 2301-2305

  Haffajee, Rebecca L ^a   Mello, Michelle M ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE; NARCOTIC ANALGESIC AGENT;

DECISION MAKING; DRUG INDUSTRY; GOVERNMENT; HEALTH CARE COST; HUMAN; INFORMATION PROCESSING; LAW SUIT; LEGAL LIABILITY; OPIATE ADDICTION; POPULATION RESEARCH; PRESCRIPTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES; ECONOMICS; EPIDEMIC; LEGISLATION AND JURISPRUDENCE;

ANALGESICS, OPIOID; DRUG INDUSTRY; EPIDEMICS; HUMANS; LIABILITY, LEGAL; OPIOID-RELATED DISORDERS; UNITED STATES;

EID: 85038415125     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1710756     Document Type: Review

References (5)

1. New data show continuing opioid epidemic in the United States. Press release of the Centers for Disease Control and Prevention Newsroom, December 16, 2016 (https://www.cdc .gov/media/releases/2016/p1216-continuing-opioid-epidemic .html).
2. Committee on Pain Management and Regulatory Strategies to Address Prescription Opioid Abuse. Pain management and the opioid epidemic: balancing societal and individual benefits and risks of prescription opioid use. Washington, DC: National Academies of Sciences Engineering Medicine, 2017 (http://nationalacademies.org/hmd/reports/2017/pain-management-and-the-opioid-epidemic.aspx).
3. Ausness RC. The role of litigation in the fight against prescription drug abuse. West VA Law Rev 2014; 116: 1117-65.
4. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy. Am J Public Health 2009; 99: 221-7.
5. U.S. Senate Homeland Security and Governmental Affairs Committee. Fueling an epidemic: Insys Therapeutics and the systematic manipulation of prior authorization. September 2017 (https://www.hsgac .senate .gov/media/minority-media/mccaskill-announces-committee-minority-roundtable-on-opioids-sales-and-marketing-following-report-detailing-insyss-systemic-manipulation-of-prior-authorization-process).